Wicki Andreas's Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Nov 16, 2022
- Accession no.
- 0001104659-22-119662
- Filed
- Nov 16, 2022
- Trade date
- Nov 14-15, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.04M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wicki AndreasCIK 0001511472 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Common Stock | SSaleDisposed | −40,317 | $59.10 | −$2,382,734.7 | 2,265,598 | Indirect | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −10,961 | $60.10 | −$658,756.1 | 2,254,637 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.